SCHEMBL1759301

SCHEMBL1759301

O=CCc1cccc2c(Br)cccc12

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PARP1 P09874 1/20 0.40
PRNP P04156 1/20 0.36
GABRA1 P14867 1/20 0.35
GABRB2 P47870 1/20 0.35
MEN1 O00255 4/20 0.34
KMT2A Q03164 4/20 0.34
TAAR1 Q96RJ0 1/20 0.32
MAPT P10636 2/20 0.32
SMN1; SMN2 Q16637 2/20 0.32
PIM1 P11309 1/20 0.32
PIM3 Q86V86 1/20 0.32
AHR P35869 1/20 0.31
IDO1 P14902 1/20 0.31
ALDH1A1 P00352 1/20 0.31
POLB P06746 1/20 0.31
RXFP1 Q9HBX9 1/20 0.31
TYMS P04818 1/20 0.31
SLC22A12 Q96S37 1/20 0.31
PLAU P00749 1/20 0.31
PNMT P11086 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3680598 0.88 MAPT (0.40) PARP1PRNPMEN1KMT2AMAPT
SCHEMBL23527388 0.80 GABRA1 (0.46) PARP1PRNPGABRA1GABRB2MEN1
SCHEMBL28879956 0.79 GABRA1 (0.43) GABRA1GABRB2KMT2ATAAR1MAPT
SCHEMBL166137 0.79 TAAR1 (0.46) GABRA1GABRB2KMT2ATAAR1MAPT
SCHEMBL29566515 0.79 TAAR1 (0.46) GABRA1GABRB2KMT2ATAAR1MAPT
SCHEMBL23527432 0.77 TAAR1 (0.38) PARP1PRNPGABRA1GABRB2MEN1
SCHEMBL23527431 0.77 TAAR1 (0.38) PARP1PRNPGABRA1GABRB2MEN1
SCHEMBL15351875 0.77 PARP1 (0.44) PARP1PRNPGABRA1GABRB2MEN1
SCHEMBL11893015 0.77 GABRA1 (0.56) PARP1PRNPGABRA1GABRB2MEN1
SCHEMBL13462948 0.76 CDK2 (0.41) PARP1GABRA1GABRB2MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2499115-A1 HEPATITIS C VIRUS INHIBITORS Bristol-Myers Squibb Company (US) 2012-09-19 EP disclosed
EP-2499127-A1 HEPATITIS C VIRUS INHIBITORS Bristol-Myers Squibb Company (US) 2012-09-19 EP disclosed
WO-2011059887-A1 HEPATITIS C VIRUS INHIBITORS BRISTOL-MYERS SQUIBB COMPANY (US) 2011-05-19 WO disclosed
WO-2011059850-A1 HEPATITIS C VIRUS INHIBITORS BRISTOL-MYERS SQUIBB COMPANY (US) 2011-05-19 WO disclosed